BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/22/2026 2:34:08 AM | Browse: 0 | Download: 0
 |
Received |
|
2026-06-12 08:57 |
|
Peer-Review Started |
|
2026-06-12 08:57 |
 |
First Decision by Editorial Office Director |
|
|
|
Return for Revision |
|
2026-07-14 08:31 |
|
Revised |
|
2026-07-25 11:34 |
|
Publication Fee Transferred |
|
2026-08-20 05:14 |
|
Second Decision by Editor |
|
2026-10-08 07:40 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-10-08 08:32 |
|
Articles in Press |
|
2026-10-08 08:32 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-10-15 01:38 |
|
Publish the Manuscript Online |
|
2026-10-22 02:34 |
| ISSN |
2218-4333 (online) |
| Open Access |
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Clinical Trials Study |
| Article Title |
Clinical efficacy of integrated Chinese-Western medicine therapy for metastatic colorectal cancer
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Rui Li, Yu-Ying Xu, Bei-Bei Wu, Meng-Meng Wang, Liang Guan, Bo-Run Li, Yu-Wei Wang, Yu-Fei Yang and Bo Pang |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Capital Health Research and Development Special Program |
No. 2022-1-4171 |
| Evidence-Based Medicine Special Project of Xiyuan Hospital, China Academy of Chinese Medical Sciences |
No. XYZX0201-19 |
|
| Corresponding Author |
Bo Pang, PhD, Professor, Department of Oncology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, No. 1 Xiyuan Caochang, Haidian District, Beijing 100091, China. drpangbo@gmail.com |
| Key Words |
Target trial emulation; Integrated Chinese-Western medicine; Metastatic colorectal cancer; Real-world study; Inverse probability weighting |
| Core Tip |
In this multicenter retrospective cohort of patients with metastatic colorectal cancer, oral Chinese herbal medicine use for ≥ 3 months was associated with longer overall and cancer-specific survival after inverse probability weighting. The therapeutic principle was standardized, whereas prescriptions were individualized according to syndrome differentiation. Because exposure was defined by observed treatment duration, immortal time bias and residual confounding remain possible. These hypothesis-generating findings require prospective confirmation using landmark and time-varying exposure analyses. |
| Publish Date |
2026-10-22 02:34 |
| Citation |
Li R, Xu YY, Wu BB, Wang MM, Guan L, Li BR, Wang YW, Yang YF, Pang B. Clinical efficacy of integrated Chinese-Western medicine therapy for metastatic colorectal cancer. World J Clin Oncol 2026; 17(10): 124301
|
| URL |
https://www.wjgnet.com/2218-4333/full/v17/i10/124301.htm |
| DOI |
https://doi.org/10.5306/wjco.124301 |
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.
